The article, "surgical aortic valve replacement in octogenarians: single-center perioperative outcomes and 5-years survival", was reviewed.The article presented a retrospective, single center study to evaluate perioperative outcome and long-term survival after surgical aortic valve replacement (savr) in octogenarians, comparing patients with low surgical risk.Devices included in this study were edwards perimount, magna ease, sorin crown, abbott trifecta gt, edwards intuity elite, livanova perceval/perceval plus.The article concluded that savr in patients =80yo is associated with low in-hospital mortality, although a significant proportion of patients develop complications.Long-term follow-up up to 5 years after surgery is acceptable in octogenarians with low surgical risk.[the primary and corresponding author was tiago velho, cardiothoracic surgery department, (b)(6) hospital, (b)(6) portugal, with corresponding email: (b)(6)] the time frame of the study was from january 2017 to january 2021.A total of 195 patients were included in this study, of which 12 (6.2%) received an abbott device.The average age was 82 years and the gender majority was male.Comorbidities included hypertension, diabetes mellitus, dyslipidemia, chronic kidney disease, peripheral vascular disease, cerebrovascular disease, chronic lung disease, ischemic cardiopathy, atrial fibrillation.
|